Comar, a specialty packaging, device, and component supplier serving the medical, pharmaceutical, consumer healthcare, personal and home care, food and beverage, and other niche market segments is building a custom facility in Rancho Cucamonga, CA. Comar will consolidate current employees, equipment, and operations from the existing Rancho Cucamonga and Garden Grove plants into this new state-of-the-art facility.

The new 230,000 sq. ft. facility will be ISO 13485 certified, cGMP compliant, and FDA registered and will house dedicated injection blow molding, injection stretch blow molding, and injection molding cells. 26,000 sq. ft. of the facility will have ISO Class 8 Injection Molding and assembly cleanrooms with room for expansion. The new facility will feature a full-service mold prototyping lab, and dedicated mold sampling and development equipment to enable Comar to rapidly bring customers from ideation, to design, to prototype, to full production.

“This transformational investment is an exciting milestone for our organization,” said Mike Ruggieri, chief executive officer, Comar. “We have an opportunity to create a purpose-built facility that will enhance the employee experience, delight our customers, and provide a path for significant continued growth. This new facility will provide best-in-class medical device production areas and significant additional capacity to grow with our customers across product lines and market segments.”
 
Comar has secured the new facility and submitted drawings and permit applications. The goal is to begin construction in the spring of 2020 and complete move in and production startup of the new facility by the end of 2020. The facility will support manufacturing of complex finished medical devices and sub-assemblies incorporating injection molding, blow molding, high speed assembly, testing, and finished device pack out.

Pete Scharber, vice president direct sales, Comar, said, “Combining our team into a single campus creates the opportunity for employees to strengthen and grow their expertise to support our customer’s needs. We are excited to amplify the Comar value proposition for our medical customers and create additional avenues to collaborate, reduce costs, mitigate risk, and further partner in their success as a single source of supply.”